(Q88218201)
Statements
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation (English)
M Capobianco
A di Sapio
M Malentacchi
S Malucchi
M Matta